Successful conversion therapy for presumed granulocyte colony-stimulating factor–producing hepatocellular carcinoma: a case report - Takeaways - MDSpire

Successful conversion therapy for presumed granulocyte colony-stimulating factor–producing hepatocellular carcinoma: a case report

  • By

  • Qian Chen

  • Taian Chen

  • Xu Zhang

  • Ming Zhang

  • June 3, 2026

  • 0 min

Share

  • 1

    G-CSF-producing hepatocellular carcinoma (HCC) is rare and often associated with aggressive tumor behavior and poor prognosis.

  • 2

    The patient in this case had no symptoms but presented with a massive tumor and significant leukocytosis.

  • 3

    Combination therapy with TACE, targeted therapy, and immunotherapy successfully downstaged the tumor to a resectable state.

  • 4

    Postoperative analysis confirmed strong G-CSF expression in the tumor tissue, supporting the diagnosis of G-CSF-producing HCC.

  • 5

    No recurrence was observed at the 6-month follow-up, indicating a favorable outcome after the combined therapeutic approach.

Original Source(s)

Successful conversion therapy for presumed granulocyte colony-stimulating factor–producing hepatocellular carcinoma: a case report

  • by Qian Chen, Taian Chen, Xu Zhang, Ming Zhang

  • June 3, 2026

Related Content

Leveraging deep learning and explainable AI for effective liver tumor classification from CT scan images

HLA matching in contemporary haematopoietic cell transplantation: Recommendations from the EBMT Practice Harmonisation and Guidelines Committee

Chemotherapy-related cognitive impairment and non-pharmacological interventions targeting the nervous system: a systematic review